Tangible Shareholders Equity (Annual)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Ironwood Pharmaceuticals, Inc. (IRWD) had Tangible Shareholders Equity of $-263.88M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$296.15M
Net Income	$24.02M
Cost of Goods Sold	--
Gross Profit	$296.15M
Operating Expenses	$197.65M
Operating Income	$98.50M
Non-Operating Income/Expense	$-28.48M
Pre-Tax Income	$70.03M
Normalized Pre-Tax Income	$70.03M
Income after Taxes	$24.02M
Income from Continuous Operations	$24.02M
Consolidated Net Income/Loss	$24.02M
Normalized Income after Taxes	$24.02M
EBIT	$98.50M
EBITDA	$100.38M
Weighted-Average Shares Outstanding (Basic)	161.84M
Weighted-Average Shares Outstanding (Diluted)	162.98M
Earnings per Share (EPS) (Basic)	$0.15
Earnings per Share (EPS) (Diluted)	$0.15
Balance Sheet Financials
Current Assets	$274.18M
Property, Plant, and Equipment	$3.41M
Long-Term Assets	$122.72M
Total Assets	$396.90M
Current Liabilities	$242.22M
Long-Term Debt	$385.00M
Long-Term Liabilities	$416.52M
Total Liabilities	$658.74M
Common Equity	$-261.83M
Tangible Shareholders Equity	$-263.88M
Shareholders Equity	$-261.83M
Common Shares Outstanding	163.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$127.04M
Cash Flow from Investing Activities	$-0.03M
Cash Flow from Financial Activities	$0.22M
Beginning Cash	$88.56M
End Cash	$215.46M
Increase/Decrease in Cash	$126.90M
Stock-Based Compensation	$17.25M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.13
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	3.13
Debt to Equity Ratio	-2.23
Gross Margin	100.00%
Operating Margin	33.26%
EBIT Margin	33.26%
EBITDA Margin	33.90%
Pre-Tax Profit Margin	23.64%
Profit Margin	8.11%
Free Cash Flow	$127.01M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.75
Inventory Turnover	--
Receiveable Turnover	6.34
Days Sales in Receivables	57.61
Return on Equity	-9.17%
Return on Tangible Equity	-9.10%
Return on Assets	6.05%
Return on Investments	19.50%
Book Value Per Share	$-1.61
Free Cash Flow per Share	$0.78
Operating Cash Flow per Share	$0.78

Data from Zacks Investment Research, Inc.